Skip to main content
BOLT logo
BOLT
(NASDAQ)
Bolt Biotherapeutics, Inc.
$3.35-- (--)
Loading... - Market loading

Bolt Biotherapeutics (BOLT) Stock Price & Financial Analysis

Bolt Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.20 - $3.35
52-Week High$7.20
52-Week Low$3.75
Open$3.30
Volume15.95K
Average Volume (3M)20.39K
Market Cap6.45M
Shares Outstanding1.87M
Price to Sales (P/S)1.17
Price to Book (P/B)0.38
EV/EBITDA-0.65
Revenue (TTM)6.50M
Net Income (TTM)-29.58M
Free Cash Flow (TTM)-42.46M
EPS (TTM)$-15.92
Profit Margin-455.15%
Operating Margin-463.44%
Return on Equity (ROE)-149.23%
Debt to Equity1.13
50-Day MA$4.22
200-Day MA$4.89
52-Week Change-27.29%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Bolt Biotherapeutics

What is the current stock price for BOLT?

As of the latest trading session, BOLT stock trades at $3.35. The 52-week range is $3.75–$7.20, with a day range of $3.20–$3.35.

What is the P/E ratio for BOLT?

The P/E ratio (Price-to-Earnings) for BOLT is shown in the Key Statistics section. This valuation metric helps compare Bolt Biotherapeutics, Inc. to industry peers.

Does BOLT pay dividends?

Bolt Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BOLT?

Analyst ratings and recommendations for BOLT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BOLT?

Bolt Biotherapeutics's market capitalization is $6.3M, classifying it as a micro-cap company. Bolt Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.